glp-1 receptor agonist pancreatitis risk meta-analysis RAs and Pancreatitis: No Significant Increase Found in | Yasir Elamin posted on the topic Benefit-Risk Assessment of GLP-1 Receptor
Description
It is well-known that the gut metabolite sodium butyrate (NaB) could promote GLP-1 secretion from intestinal L cells
Pausing GLP-1 Therapy Led to Consequences BMJ Medicine , followed more than 333,000 American veterans with type 2 diabetes for three years
and binge eating, loss-of-control eating, and food rumination are reduced
Epinephrine-induced insulin resistance in man
Future research should focus on elucidating the complex mechanisms underlying their psychological effects and integrating mental health considerations into therapeutic strategies
